| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | negative regulation of response to endoplasmic reticulum stress | 8.24e-05 | 49 | 6 | 2 | GO:1903573 | |
| GeneOntologyBiologicalProcess | regulation of response to endoplasmic reticulum stress | 3.18e-04 | 96 | 6 | 2 | GO:1905897 | |
| GeneOntologyBiologicalProcess | G2/M transition of mitotic cell cycle | 7.94e-04 | 152 | 6 | 2 | GO:0000086 | |
| GeneOntologyBiologicalProcess | cell cycle G2/M phase transition | 1.00e-03 | 171 | 6 | 2 | GO:0044839 | |
| Pubmed | 6.94e-07 | 8 | 6 | 2 | 18768805 | ||
| Pubmed | Liver X receptor beta and thyroid hormone receptor alpha in brain cortical layering. | 1.36e-06 | 11 | 6 | 2 | 20566868 | |
| Pubmed | 1.64e-06 | 12 | 6 | 2 | 22828627 | ||
| Pubmed | 2.97e-06 | 16 | 6 | 2 | 29507213 | ||
| Pubmed | Centrosome anchoring regulates progenitor properties and cortical formation. | 7.43e-06 | 25 | 6 | 2 | 32238932 | |
| Pubmed | 1.15e-05 | 31 | 6 | 2 | 22925884 | ||
| Pubmed | 1.15e-05 | 31 | 6 | 2 | 19796621 | ||
| Pubmed | Defining the molecular character of the developing and adult kidney podocyte. | 1.83e-05 | 39 | 6 | 2 | 21931791 | |
| Interaction | RNASE10 interactions | 3.32e-06 | 10 | 6 | 2 | int:RNASE10 | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 132 | 6 | 2 | 4152529611eeacf0c547e2a134d5b98c45426b13 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Biphasic|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 2.03e-04 | 167 | 6 | 2 | 9062577a4b7902c9a888d706589d1b05221c0fa8 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 169 | 6 | 2 | bb43abad2c049b7f4d307737347290e01b3339a3 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 169 | 6 | 2 | 5f18e3f40a5b1b167903f37516ec8181e889c7c5 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 169 | 6 | 2 | 8bfa2d3bb541d02f55d7c95b8fd156c8403befca | |
| ToppCell | 3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell-SMG_mucous-SMG_mucous_L.0.6.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.21e-04 | 174 | 6 | 2 | b1b54e4e23df8cfc04bf298d5c53de203a38b267 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.31e-04 | 178 | 6 | 2 | e32f5ed7a492edfa7073416008b1fcfae6b854ad | |
| ToppCell | Mesenchymal_cells-Ng2+_MSCs|Mesenchymal_cells / Lineage and Cell class | 2.55e-04 | 187 | 6 | 2 | e899b906409f3fad69cb3d3c6432c3fd862ae3c1 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.55e-04 | 187 | 6 | 2 | db771e952f71a12886c2dbc77c6cd07054ef809a | |
| ToppCell | Frontal_cortex-Endothelial|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.58e-04 | 188 | 6 | 2 | a43392dbd10fc7dbfb31be39b8af8a7ea121c894 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.63e-04 | 190 | 6 | 2 | cf463b2f227f3cc7d3fd296c810c0cbe51cbee72 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.74e-04 | 194 | 6 | 2 | 8b81f039f5b25d35a4d5a41b27d4d9360ba22f15 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.77e-04 | 195 | 6 | 2 | 4a5d2f62aad5817d077177bf8b4ff0e46d3b8d97 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.77e-04 | 195 | 6 | 2 | 7a32a8535c29b819dacba901d0658280a2631c94 | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 2.80e-04 | 196 | 6 | 2 | 8f0f72ead06abe02b575e443552eacc2151077ef | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.83e-04 | 197 | 6 | 2 | 2ca5ebb708935a90b12b8e98a22ae2d664ed002e | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.83e-04 | 197 | 6 | 2 | 2f72fd9a5b6d62c24a95ed2246194ea7458c0f12 | |
| ToppCell | Severe-B_memory-0|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.86e-04 | 198 | 6 | 2 | 9cc75d14f1220fe15e530115f6dff09c31f07f7c | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.86e-04 | 198 | 6 | 2 | 6a539d3b47bd2d4a7ad5c67cad23facffc0ac45f | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.89e-04 | 199 | 6 | 2 | 7b1b3b108d817fb3b50a710c3146b30bcf9c2f6b | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.89e-04 | 199 | 6 | 2 | bf138cc692df727e087d140c014149ee5da00d9d | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.89e-04 | 199 | 6 | 2 | d65ee89d5c7e8ed693d58e6a6de09565840e11c5 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.89e-04 | 199 | 6 | 2 | f2ad641f36c577ff7019e88ad6b73ed7e46d8c74 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-early_osteoblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.91e-04 | 200 | 6 | 2 | 16a7c398626b6e82b394eb3ef013bda3a788659d | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.91e-04 | 200 | 6 | 2 | 3c898e81444b001835c3f1bbc68183078701b135 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.91e-04 | 200 | 6 | 2 | 780d47f8eff630020dfae32218de495a7e9dbad6 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.91e-04 | 200 | 6 | 2 | 28dd127787a57276253548d1f030814b1af64481 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.91e-04 | 200 | 6 | 2 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 | |
| Drug | cyprodinil | 3.47e-07 | 4 | 6 | 2 | CID000086367 | |
| Drug | methoxyamine hydrochloride | 5.79e-07 | 5 | 6 | 2 | CID000011639 | |
| Drug | AC1L1C6L | 2.86e-05 | 32 | 6 | 2 | CID000001763 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 8.34e-04 | 172 | 6 | 2 | 3979_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 8.73e-04 | 176 | 6 | 2 | 6972_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 8.83e-04 | 177 | 6 | 2 | 4770_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 9.03e-04 | 179 | 6 | 2 | 6951_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 9.33e-04 | 182 | 6 | 2 | 6932_UP | |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 10uM; PC3; HT_HG-U133A | 1.05e-03 | 193 | 6 | 2 | 3773_DN | |
| Drug | Isradipine [75695-93-1]; Down 200; 10.8uM; PC3; HT_HG-U133A | 1.06e-03 | 194 | 6 | 2 | 6347_DN | |
| Drug | trifluoperazine dihydrochloride; Up 200; 10uM; HL60; HT_HG-U133A | 1.07e-03 | 195 | 6 | 2 | 6183_UP | |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.07e-03 | 195 | 6 | 2 | 3523_DN | |
| Disease | apolipoprotein A 1 measurement | 1.15e-02 | 848 | 6 | 2 | EFO_0004614 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EPPDGWEINPGGPAE | 446 | Q96BA8 | |
| DGEQGPPQDEEGWPP | 11 | Q9Y4H4 | |
| PPPQGETGKEGWDPA | 1321 | P48681 | |
| KEEGPEPWPGGPDPD | 31 | P55055 | |
| EEEPPQGPEGQPEWK | 491 | Q9UPV0 | |
| VQPGWPEDPILGEDE | 76 | Q5GAN6 |